You searched for "continence"

654 results found

The Urology Foundation

The Urology Foundation (TUF) is the only charity in the United Kingdom that raises money for research into all types of urological disease. Our ultimate aim as a charity is to discover the causes of urology cancers and conditions, to...

How an ergonomic design is helping women overcome barriers in ISC

Urinary incontinence, or loss of bladder control, is a frustrating problem for millions of people. Never knowing when and where one might have an accident can affect everything: from work to family and social life. It happens to both men...

The Urology Foundation – 2019 Report

It has been another busy year for The Urology Foundation in our mission to end the suffering caused by urology disease. We’ve taken big strides in some of the most crucial areas of our work as we work to prevent, treat and cure all urology disease.

How to set up and run a cadaveric dissection course

Conducting and implementing a cadaveric dissection course requires careful planning. Rachel Edmiston, Rajesh Anmolsingh, Omar Mirza and Nirmal Kumar offer a guide to individuals highlighting the licensing and legal processes involved with the use, preservation and disposal of cadavers in...

Solifenacin for children and adolescents with overactive bladders

Solifenacin (VESIcare®) is the second-line anti-muscarinic medication of choice for my patients with overactive bladder (oxybutynin being my initial choice). However, currently, it remains unlicensed for use in children. Newgreen et al. have evaluated the long-term safety and efficacy of...

Solifenacin and mirabegron are safe and effective in combination

Antimuscarinic agents remain the mainstay of medical management of bladder overactivity. Limited somewhat by their tolerability, the new agent mirabegron, a β3-adrenoreceptor agonist, has been approved as an alternative. There is little known however about the possible synergistic effects of...

Transurethral enucleation is superior to resection for the management of LUTS secondary to BPH

This meta-analysis (Level 1b evidence) examined the efficacy and safety of two primary transurethral therapies used in the management of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH), enucleation (HoLEP – holmium laser enucleation of prostate, ThuLEP,...

Long-term risks of augmenting the bladder in spina bifida patients

Bladder augmentation is utilised to treat children with neuropathic bladders secondary to spina bifida that results in hostile urodynamics, renal deterioration and / or urinary incontinence. Whilst it is associated with an improved quality of life and low mortality, it...

New Stress Urinary Incontinence Device, Efemia Bladder Support, now on NHS prescription

AGHealth, distributors of innovative obstetric and gynaecology devices, are proud to announce that Efemia Bladder Support is now on NHS Prescription, helping improve the lives of women affected by Stress Urinary Incontinence (SUI).

Men's Liberty case study reduces catheter days with ZERO CAUTI: Management of Urinary Incontinence in Retracted Penis

Men’s Liberty™ is the innovative alternative to traditional male external catheters.

Contiform – is available on prescription

Despite the rumours of Contiform’s demise that have been greatly exaggerated, and that...

Can transcutaneous peroneal nerve stimulation treat OAB?

The peroneal nerve follows sacral, pudendal, and tibial nerves as a target for overactive bladder (OAB) treatment. This multicentre prospective randomised RCT compared a transcutaneous electrical neuromodulation system (eTNM) at-home treatment once daily for 30 minutes to solifenacin 5mg once...